Cromoglicic acid is a medication used to treat asthma, allergic reactions of the eyes and nose, as well as other mast cell reactions. A chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells.
- Mechanism
- Curator reviewed
Cromoglicate inhibits degranulation of mast cells, subsequently preventing the release of histamine and slow-reacting substance of anaphylaxis (SRS-A), mediators of type I allergic reactions. Cromoglicate also may reduce the release of inflammatory leukotrienes. Cromoglicate may act by inhibiting calcium influx.
- Primary indication
- For the management of patients with bronchial asthma.Curator reviewed · 13 structured indications
- Formula / weight
- C23H16O11 · 468.3665 g/mol (avg)
- First approval
- Canada, 1997 · United States, 1982
- Also known as
- Cromoglicate · Cromoglycate · Cromoglycic acid · Cromolyn
- Code names
- R03BC01
- Brand names
Resolves to
IMZMKUWMOSJXDT-UHFFFAOYSA-NSMILESOC(COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O)COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=OWhat you can answer from here — as of September 23, 2026
Which drugs share a target with Cromoglicic acid, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account